Tagged with HE

Hong Kong Andrea Chang, general manager of Eisai Hong Kong explains the importance of the firm’s FDA-approved Biogen-partnered Alzheimer’s disease (AD) product, particularly in Hong Kong where some 20 percent of the population is aged 65 or older. In addition, she outlines Eisai’s oncology and neurology-focused portfolio; the potential provided by Hong…

Saudi Arabia Established as one of the initiatives launched by the Ministry of Health within Saudi Arabia’s Vision 2030, the Saudi National Institute for Health (Saudi NIH) aims to strengthen the Kingdom’s biomedical research landscape, funding high impact research and enhancing alignment with regulatory bodies. CEO and former academic Prof Fars Alanazi…

Mexico Joao Carapeto outlines Roche Diagnostics’ commitment to innovation, prevention, and diagnostics, emphasizing the need for robust partnerships and increased investment in early detection to address Mexico’s healthcare challenges. He highlights the significance of managing an aging population and improving the quality of life through advanced healthcare solutions.   Prevention and…

Mexico FUNSALUD is a leading Mexican think tank focused on improving public health through research, advocacy, and promoting public-private partnerships. As Mexico prepares to welcome a new president, FUNSALUD’s Hector Valle casts his eye over the evolving healthcare landscape in terms of both progress made in addressing access gaps and how…

Mexico This year has seen no less than five GM changes at international pharma companies’ Mexican affiliates. Pfizer, MSD, Roche, Sanofi and Gilead have all taken on new local leadership. In some cases, the appointments represent a first for affiliates that have never had female leaders while in others they coincide…

United Kingdom The newly elected UK government’s Secretary of State for Health and Social Care Wes Streeting has a full plate of challenges ahead. Britain’s National Health Service (NHS) is plagued with a chronic lack of funding, staffing crunches and backlogs, while the country’s life sciences sector is seemingly in decline. Streeting…

India Poised to overtake Japan and become the world’s fourth-largest economy by 2025 according to the latest International Monetary Fund estimates and now registering heady year-on-year growth rates exceeding eight percent, India’s overall business outlook appears increasingly rosy with industry reaping the rewards from rising per capita GDP, enhanced purchasing power,…

Global As pharma navigates issues ranging from the US Inflation Reduction Act to new EU pharmaceutical legislation, and the impact of global unrest on supply chains, the industry is experiencing other shifts as reflected in Pharma Exec’s 2024 Top 50 Companies. Based on 2023 drug revenue performance from global drug makers,…

South Africa A leading voice in the global fight against HIV, Professor Linda-Gail Bekker works across both scientific research and activism. As CEO and founder of the Desmond Tutu Health Foundation, Prof Bekker has helped change the course of the HIV/AIDS epidemic in South Africa. Her organisation has brought the latest HIV…

Japan A roundup of the most important stories coming out of Japan’s pharma industry, including the sharp increase in deaths linked to Kobayashi supplements; the partnership between Moderna and Mitsubishi Tanabe to jointly promote Moderna’s mRNA respiratory vaccine portfolio; the country’s move to to support domestic antibiotics production; Takeda’s licenscing agreement…

Mexico Drawing on an industry track record of over 25 years, Fernando Fogarin has recently become the strategic project lead for emerging markets at women’s health specialist Organon. He shares his priorities and the particularities of the Mexican market, discussing the positive impact of the country’s upcoming biosimilars reform; Organon’s efforts…

Mexico Mexico’s president-elect Claudia Sheinbaum recently revealed some of her key cabinet choices, naming eminent physician and researcher David Kershenobich as the country’s new health secretary. When Kershenobich takes office in October he will be inheriting a healthcare system rife with medicine shortages, partially adopted systems and inadequate resources. However, rather…